giraffe.bioCrawled Oct 16, 2026
Giraffe Bio develops biochemical reagents designed for existing flotation circuits to improve mineral selectivity and recovery.
Giraffe Bio develops biochemical reagents designed for existing flotation circuits to improve mineral selectivity and recovery.
Giraffe Bio, an Argentine biotech startup, secures a $6.4 million seed round to develop microbial solutions for extracting more copper from existing mines. The funding is led by Orion Industrial Ventures, with participation from BHP Ventures, Twynam, and AIR Capital. Founded in 2024 by Alejandro Buffo Sempé and Juan Pablo Fernández, the company leverages biotechnology to enhance copper recovery efficiency in active mining operations.
Oct 2026 · The Investor SocietyNews article
Giraffe Bio secures $6.4 million in seed funding to advance microbial solutions for copper extraction. The round is led by Orion Industrial Ventures, targeting enhanced recovery efficiency in mining operations. The company applies biotechnology to optimize resource extraction processes.
Oct 2026 · LatamListNews article
Giraffe Bio secures **$6.4 million in Seed funding** to commercialize biomolecules that enhance copper mining efficiency. The round, led by **Orion Industrial Ventures**, includes backers like **BHP Ventures** and **Air Capital**, targeting the growing demand driven by AI data centers and global electrification. The company’s reagents aim to address an impending copper supply crunch by improving extraction processes.
Oct 2026 · SOSVNews article
Giraffe Bio secures $6.4 million in seed funding to expand production of biochemical flotation reagents. These reagents enable copper mines to improve copper recovery rates without needing additional equipment. The company targets scaling its technology for broader adoption in the mining industry.
Oct 2026 · GlobeNewswireNews article